5-year follow-up of the PROFILE trial in 386 adults newly diagnosed with Crohn's disease: Crohn's-related abdominal surgery occurred in 26 patients after step-up vs 6 after top-down infliximab plus immunomodulator (aHR for earlier surgery with step-up 5·23, 95% CI 1·99–13·76).
RCTn = 386
Noor et al. Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial